1. Home
  2. LGND vs PATK Comparison

LGND vs PATK Comparison

Compare LGND & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • PATK
  • Stock Information
  • Founded
  • LGND 1987
  • PATK 1959
  • Country
  • LGND United States
  • PATK United States
  • Employees
  • LGND 68
  • PATK N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • PATK Auto Parts:O.E.M.
  • Sector
  • LGND Health Care
  • PATK Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • PATK Nasdaq
  • Market Cap
  • LGND 3.2B
  • PATK 3.5B
  • IPO Year
  • LGND 1992
  • PATK N/A
  • Fundamental
  • Price
  • LGND $184.49
  • PATK $98.44
  • Analyst Decision
  • LGND Strong Buy
  • PATK Buy
  • Analyst Count
  • LGND 8
  • PATK 10
  • Target Price
  • LGND $144.71
  • PATK $104.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • PATK 254.2K
  • Earning Date
  • LGND 08-05-2025
  • PATK 10-30-2025
  • Dividend Yield
  • LGND N/A
  • PATK 1.63%
  • EPS Growth
  • LGND N/A
  • PATK N/A
  • EPS
  • LGND N/A
  • PATK 3.69
  • Revenue
  • LGND $181,488,000.00
  • PATK $3,816,541,000.00
  • Revenue This Year
  • LGND $18.41
  • PATK $3.72
  • Revenue Next Year
  • LGND $18.87
  • PATK $5.73
  • P/E Ratio
  • LGND N/A
  • PATK $26.65
  • Revenue Growth
  • LGND 53.40
  • PATK 6.09
  • 52 Week Low
  • LGND $81.74
  • PATK $72.99
  • 52 Week High
  • LGND $129.90
  • PATK $116.78
  • Technical
  • Relative Strength Index (RSI)
  • LGND 79.42
  • PATK 36.44
  • Support Level
  • LGND $179.40
  • PATK $98.81
  • Resistance Level
  • LGND $184.26
  • PATK $106.60
  • Average True Range (ATR)
  • LGND 4.60
  • PATK 2.72
  • MACD
  • LGND 0.44
  • PATK -0.71
  • Stochastic Oscillator
  • LGND 100.00
  • PATK 13.81

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: